Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2020

View Archived Issues

GT Biopharma advances new TriKE therapy for breast and gastrointestinal cancers

Intra-Cellular initiates clinical programs for ITI-LLAI and ITI-333

MATR3 S85C knock-in mice mimic behavioral and neuropathological features of human early-stage ALS

RCAN1 is involved in tubulointerstitial fibrosis progression by regulating mitochondrial quality

Novel lipid conjugates of APJ agonist peptides show prolonged half-life for once-daily dosing

YF17D-based COVID-19 vaccine candidate induces protective immunity within 10 days with a single dose

Max-Delbrueck-Centrum fuer Molekulare Medizin, DZNE patent chimeric autoantibody receptors

New mutant LRRK2 inhibitors identified at Merck & Co.

Compounds for treating rabies patented by Oita University Institute of Advanced Medicine

BIAL-Portela & Ca. discovers dopamine beta-monooxygenase inhibitors

3M Pharmaceuticals presents new TLR7/8 agonists

Phase IIb/III trial of Zyesami for respiratory failure in critical COVID-19 completes enrollment

Hepion reports topline low-dose data from phase IIa trial of CRV-431 in NASH

Vaxil offers update on COVID-19 vaccine research

FDA issues complete response letter for Osmotica's arbaclofen ER for MS spasticity

NUSAP1 linked to poor prognosis in chronic lymphocytic leukemia

U.K. MHRA authorizes AstraZeneca's COVID-19 vaccine for emergency supply

New clinical program studies Emergent's COVID-HIG product candidate for COVID-19 prophylaxis

COVID anniversary coincides with more transmissible strains

Final results from phase III BRIDGE study of pegunigalsidase alfa for Fabry disease

Opdivo SCLC indication withdrawn in U.S.

Polish authorities grant new indication for Dexaven to treat COVID-19

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...